Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals

Background: Racial variation in prostate canter incidence in the United Sta tes is pronounced, with African-American men having the highest rates. Whet her differences in the distribution of known or suspected risk factors amon g racial groups explain this variation is unknown. Methods: We evaluated pr ospectively the relation between prostate cancer and race among 45410 U.S. male health professionals aged 40-75 years in 1986. We used multivariable, pooled logistic regression to adjust the rate ratio (RR) for potential diet ary and lifestyle risk factors. We also measured circulating levels of ster oid hormones, sex hormone-binding globulin, and vitamin D metabolites and l ength of the androgen receptor gene CAG repeat in a sample of African-Ameri can (n = 43), Asian (n = 52), and white (n = 55) participants and assessed variation by race in these possible prostate epithelial cell growth mediato rs by use of analysis of variance. Statistical tests were two-sided. Result s: The age-adjusted RR for prostate cancer was 1.73 (95% confidence interva l [CI] = 1.23-2.45) for African-American men compared with white men. After multivariate adjustment, the RR increased to 1.81 (95% CI = 1.27-2.58). Th e rate of prostate cancer did not differ between Asians and whites. Steroid hormone and 1,25-dihydroxyvitamin D levels did not vary appreciably by rac e. However, the mean number of androgen receptor gene CAG repeats was lower among African-Americans (mean +/- standard deviation = 20.1 +/- 3.5) than among whites (22.1 +/- 3.1; P = .007) and Asians (22.1 +/- 3.9; P = .009). Conclusions: Our results confirm the elevated incidence of prostate cancer among African Americans and show that it is not explained by differences in the distribution of possible dietary and lifestyle risk factors in this co hort. Racial variation in length of the androgen receptor gene CAG repeat m ay explain a small part of the excess risk of prostate cancer among African -American men in this cohort.